Quick Takeaways
- STATE STREET CORP filed SCHEDULE 13G for HALOZYME THERAPEUTICS INC COMMON STOCK (HALO).
- Disclosed ownership: 4.9%.
- Date of event: 31 Mar 2025.
STATE STREET CORP - 31 Mar 2025 SCHEDULE 13G Report for HALOZYME THERAPEUTICS INC COMMON STOCK (HALO)
- Filing Manager
- STATE STREET CORP
- Reporting Manager
- STATE STREET CORPORATION
- Symbol
- HALO
- Shares outstanding
- 123,530,755 shares
- Disclosed Ownership
- 6,053,007 shares
- Ownership
- 4.9%
- Form type
- SCHEDULE 13G
- Filing time
- 13 May 2025, 11:18:25 UTC
- Date of event
- 31 Mar 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"STATE STREET CORP disclosed 4.9% ownership in HALOZYME THERAPEUTICS INC COMMON STOCK (HALO) on 31 Mar 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 13 May 2025, 11:18.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| STATE STREET CORPORATION | 4.9% | 6,053,007 | 0 | 5,562,493 | ELIZABETH SCHAEFER | SENIOR VICE PRESIDENT, CHIEF ACCOUNTING OFFICER |